Five things for pharma marketers to know: Friday, September 21, 2018
Federal prosecutors investigate pharma kickbacks; FDA to fast-track e-cigarette designed to curb teen use; Medtronic to acquire Mazor Robotics.
News
Wiesel’s wisdom a morality model for healthcare
For an industry hungry for ethical role models who transcend our fragmented healthcare system, a new book brings Elie Wiesel’s legacy into focus.
Novartis revises bonus structure to promote ethical behavior
The drugmaker has refocused on ethics to move past the Michael Cohen scandal.
PCMA appoints AdvaMed veteran J.C. Scott as CEO
Outgoing Pharmaceutical Care Management Association chief executive Mark Merritt is stepping down after 15 years.
Five things for pharma marketers to know: Thursday, September 20, 2018
Amicus acquires rare disease gene therapy programs; Data shows black patients are underrepresented in clinical trials; Takeda acquires Molecular Templates.
2e Creative acquires Indiana marketing, sales agency Fire & Rain
It is the first acquisition for St. Louis-based 2e.
Five things for pharma marketers to know: Wednesday, September 19, 2018
AbbVie accused of kickbacks to push Humira; Opioid crisis becomes major midterm campaign theme; GSK hires former Boehringer Ingelheim chief medical officer.
FDA turns attention to vapes in latest version of Real Cost anti-tobacco campaign
An estimated 10.7 million teens are vaping or thinking about it.
Scout joins forces with Rare Expertise to speed up patient journey in rare disease
The joint venture will tie together Scout’s rare disease marketing expertise with Rare Expertise’s clinical development and commercial services.
Five things for pharma marketers to know: Tuesday, September 18, 2018
Senate overwhelmingly passes opioid bill; Novo Nordisk plans layoffs in Denmark, China; Justice Department OKs Cigna’s acquisition of Express Scripts.
Want to read more?
Please login or register first to view this content.
